Melanoma, Nonmelanoma Skin Cancer Associated With Reduced Risk for Alzheimer’s

There is a significantly decreased risk for a diagnosis of Alzheimer disease (AD) in patients with malignant melanoma (MM), as well as in those with nonmelanoma skin cancer (NMSC), according to the results of a study conducted in a large, single-center, Midwestern US patient population and published in the Journal of the European Academy of Dermatology and Venereology.

AACR 2018: A patient-researcher collaboration targeting ROS1 cancer

Cancer patients have often organized support and informational groups around their disease types.

Skin cancer caught earlier by spouses, diagnosed more accurately by dermatologists

Two studies published in JAMA Dermatology report on the detection of early skin cancers in married couples, and the accuracy of diagnosis by dermatologists compared to physician assistants (PAs).

Pre-Surgical Immunotherapy Identifies Potential Benefit, Risk of Recurrence in Melanoma

For patients with melanoma, administration of a PD-1 checkpoint blockade therapy in the neoadjuvant setting – meaning it was given before the main treatment – could result in improved outcomes, according to study results presented at the 2018 American Association for Cancer Research (AACR) Annual Meeting.

Cancer in the News

Feature Articles

Combination immunotherapy may have failed in the Incyte/Merck trial, but it’s here to stay

The failure of Incyte’s Phase 3 clinical trial of epacadostat combined with Keytruda, Merck’s breakthrough checkpoint inhibitor, for people newly diagnosed with melanoma was a big disappointment to the companies, the pharmaceutical industry, and patients.

Read the full story

Posted in Melanoma In The News, Information

Targeting telomerase as therapeutic strategy for melanoma

Targeting telomerase was effective at killing NRAS-mutant melanoma cells, and the impact was further enhanced when the strategy was paired with an inhibitor of mitochondrial function, according to study results by The Wistar Institute published in Oncogene.

Read the full story

Posted in Melanoma In The News, Information

Melanoma Research Alliance Announces $11.8 Million in 28 New Grants to Advance Melanoma Research

On the cusp of Melanoma Awareness Month, the Melanoma Research Alliance (MRA), the largest non-profit funder of melanoma research, announced funding for 28 research grants totaling $11,800,000.

Read the full story

Posted in Melanoma In The News, Information

Older Patients with Metastatic Melanoma May Benefit from Immunotherapy

Age should not limit which patients with metastatic melanoma receive immunotherapy, according to a new study published in JAMA Dermatology.

Read the full story

Posted in Melanoma In The News, Information

Melanoma Google Alerts

Melanoma Google Alerts is a summary of daily articles found in print and on the internet. The articles do not necessarily represent the views of Melbourne Melanoma Project

News Archives

News Categories